Search

Search Results
Results 1721 - 1730 of 1737 for glioblastoma
  • EpiCept fourth quarter revenue decreases to $0.1 million
    News - 28 Feb 2013
    EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2012, and provided an update on the Company's merger with Immune...
  • Delivering oligonucleotides the smart way
    White Paper - 1 Feb 2024
    This article from Merck explains how oligonucleotides are being delivered by multifunctional block copolymers - a form of "smart" delivery.
  • Solid tumors: Target antigens for treatment
    Equipment - 22 May 2023
    CAR-T therapy is now seeing expansion for use in cancer treatment. Sino Biological produces a large range of promising target antigens for use in the cell therapy of solid tumors.
  • Quantifying cell migration in real-time
    White Paper - 30 Mar 2023
    In this article, Sartorius writes about a novel way by which to conduct dynamic quantification of cell migration in a real-time setting.
  • Utilizing stem cells to support and aid cancer therapy
    White Paper - 4 Apr 2022
    In this article, Sino Biological discusses how stem cells can be used to support and aid cancer therapy and treatment. They discuss different types of stem cells, pathways to target and how to best...
  • Temodal
    Drug - 29 Jan 2024
    Consumer Medicine Information (CMI) about Temodal intended for persons living in Australia.
  • The role of cell adhesion molecules in immune and cancer therapy
    White Paper - 25 Oct 2022
    Cell adhesion molecules are crucial to the normal function of the immune system and normal cell function. As such, extensive research is being conducted into how these molecules could be utilized in...
  • VEGF: A consistent target for antitumor therapy
    White Paper - 30 Aug 2022
    In this article, ACROBiosystems discusses Vascular Endothelial Growth Factor (VEGF) and its enduring use as a target in antitumor therapy.
  • Temizole
    Drug - 1 Aug 2022
    Consumer Medicine Information (CMI) about Temizole intended for persons living in Australia.
  • Temozolomide Alphapharm
    Drug - 4 May 2020
    Consumer Medicine Information (CMI) about Temozolomide Alphapharm (Temozolomide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback